WO1994009755A1 - Procede et composition de prevention et/ou de traitement des pellicules et de la dermatite seborrheique - Google Patents

Procede et composition de prevention et/ou de traitement des pellicules et de la dermatite seborrheique Download PDF

Info

Publication number
WO1994009755A1
WO1994009755A1 PCT/EP1993/003060 EP9303060W WO9409755A1 WO 1994009755 A1 WO1994009755 A1 WO 1994009755A1 EP 9303060 W EP9303060 W EP 9303060W WO 9409755 A1 WO9409755 A1 WO 9409755A1
Authority
WO
WIPO (PCT)
Prior art keywords
propylene glycol
dandruff
concentration
scalp
composition
Prior art date
Application number
PCT/EP1993/003060
Other languages
English (en)
Inventor
Michael Potts
Original Assignee
Beiersdorf Ag
Surtech International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag, Surtech International Limited filed Critical Beiersdorf Ag
Priority to EP93924089A priority Critical patent/EP0666734A1/fr
Publication of WO1994009755A1 publication Critical patent/WO1994009755A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Definitions

  • This invention relates to a method and composition for the prevention and/or treatment of scaling conditions of the scalp, such as dandruff, seborrhoeic dermatitis and psoriasis.
  • Previously known methods for preventing and treating dandruff generally involve applying to the scalp various anti-dandruff agents contained in lotions, gels and shampoos.
  • anti-dandruff agents include sulphur and selenium compounds, zinc pyrrithione and bacteriostatic and bacteriacidal agents such as, for example, hexachlorophene.
  • the use of such anti-dandruff agents can give rise to adverse reactions, for example allergic reactions and erythematous lesions. Consequently, known anti-dandruff agents cannot be used in the long term and it is frequently found that dandruff symptoms recur.
  • Known anti-dandruff agents are often difficult to formulate into cosmetically acceptable compositions .
  • UK Patent No. GB 2,205,743 described the finding that propylene glycol is effective as an anti-dandruff agent and that a significant anti-dandruff effect may be observed following application of propylene glycol to the scalp, e.g. in the form of a lotion, gel or shampoo.
  • Propylene glycol when used in accordance with the teachings of GB 2,205.743. avoided undesirable side effects which occur
  • Propylene glycol has hitherto also been described for use as a diluent, thinning agent or vehicle for various pharmaceutical products including such products intended for topical use.
  • carboxylic acid derivatives as active ingredients for treating keratinization defects.
  • DE-A-2,758,484 describes the use of chenodesoxic acid as the active ingredient of anti-dandruff compositions including lotions, gels and shampoos.
  • This specification mentions propylene glycol as an ingredient of such compositions but not as an active ingredient.
  • compositions containing as active ingredient, inter alia arginine or arginine citrate.
  • Such compositions can contain relatively small proportions of propylene glycol as diluent along with relatively larger
  • GB-A-1,140,443 describes an antiseptic composition consisting of a saturated solution of salicylic acid in propylene glycol and in addition an antiseptic selected from sodium
  • compositions of GB-A-1,140,443 generally contained more than 10 wt % of salicylic acid and the patent is not concerned at all with treatment of dandruff or seborrhoeic dermatitis.
  • a possible reason for the actions of the combination therapy of the invention is that combinations of propylene glycol and
  • salicylic acid have enhanced activity against Pityrosporum ovale, an organism that is now thought to be implicated as an aetiological agent responsible for both psoriasis and seborrhoeic dermatitis and possibly also dandruff. Further the combinations of propylene glycol and salicylic acid exhibit an enhanced keratolytic action.
  • composition for use in the treatment of scaling conditions of the scalp including dandruff, seborrhoeic dermatitis and psoriasis which comprises as active ingredients, propylene glycol and salycylic acid. together with a topically acceptable excipient, the propylene glycol being present in a concentration of not greater than 50 wt % and the salicylic acid being present in a concentration of not greater than 10 wt %.
  • the concentration of propylene glycol is from to 50 wt %, most preferably from 10 to 40 wt %.
  • the salicylic acid is preferably present in a concentration of from 1 to 6 wt U, most preferably from 1 to 3 wt %.
  • compositions according to the invention may be formulated in the form of solutions, lotions or gels suitable for topical application, or in the form of a shampoo.
  • Compositions according to the invention may contain any conventional incidental adjuvents, for example, emolients, thickening agents, foaming agents, perfumes, colouring agents, stabilising agents, pH-adjusting agent and preservatives as well as water and/or ethanol.
  • Shampoos in accordance with the invention typically contain conventional detergent and/or surfactants to provide any necessary foaming and cleansing action.
  • the shampoos will contain perfuming ingredients and colouring agents and if desired other agents to make the product cosmetically acceptable, e.g. pearling agents, thickeners etc.
  • a method of treating dandruff and/or seborrhoeic dermatitis and/or psoriasis which comprises applying a composition according to the invention to the affected region.
  • compositions may be applied to the affected region at regular intervals of, for example. 1-5 and preferably 1-10 days.
  • the shampoo should be left on the hair, for example, for 1-5 minutes to enable the therapeutic effects of the proplylene glycol and salicylic acid to occur.
  • a lotion or gel also in accordance with the invention should be rubbed into the scalp and left in situ for 10 to 15 minutes. This combination of treatments has been found further to enhance the efficacy of the combination therapies of the invention.
  • the invention thus further provides a kit for use in the treatment of scaling conditions of the scalp, including dandruff, seborrhoeic dermatitis and psoriasis, comprising
  • a specific combination therapy according to the invention comprises

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

Composition destinée à être utilisée dans le traitement des desquamations du cuir chevelu telles que les pellicules, la dermatite séborrhéique et le psoriasis, cette composition renfermant comme ingrédients actifs du propylène glycol et de l'acide salicylique qui sont associés à un excipient acceptable topiquement, le propylène glycol ayant une concentration inférieure ou égale à 50 % en poids et l'acide salicylique une concentration inférieure ou égale à 10 % en poids.
PCT/EP1993/003060 1992-11-03 1993-11-02 Procede et composition de prevention et/ou de traitement des pellicules et de la dermatite seborrheique WO1994009755A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP93924089A EP0666734A1 (fr) 1992-11-03 1993-11-02 Procede et composition de prevention et/ou de traitement des pellicules et de la dermatite seborrheique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9223034.1 1992-11-03
GB929223034A GB9223034D0 (en) 1992-11-03 1992-11-03 Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis

Publications (1)

Publication Number Publication Date
WO1994009755A1 true WO1994009755A1 (fr) 1994-05-11

Family

ID=10724472

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1993/003060 WO1994009755A1 (fr) 1992-11-03 1993-11-02 Procede et composition de prevention et/ou de traitement des pellicules et de la dermatite seborrheique

Country Status (3)

Country Link
EP (1) EP0666734A1 (fr)
GB (1) GB9223034D0 (fr)
WO (1) WO1994009755A1 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013048A1 (fr) * 1993-11-12 1995-05-18 The Procter & Gamble Company Compositions desquamantes contenant de l'acide salicylique ainsi que des composes zwitterioniques
WO1996001101A1 (fr) * 1994-07-01 1996-01-18 The Procter & Gamble Company Compositions de desquamation
WO1996011572A1 (fr) * 1994-10-14 1996-04-25 Sven Moberg Composition antimicrobienne
FR2740679A1 (fr) * 1995-11-03 1997-05-09 Letourneur Raymond Composition de shampooings et traitements a base d'eau de pluie
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
WO1997048374A2 (fr) * 1996-06-20 1997-12-24 The Procter & Gamble Company Systemes de diffusion de parfum dans des compositions de savon liquide
WO1997048375A2 (fr) * 1996-06-20 1997-12-24 The Procter & Gamble Company Systeme de liberation de parfum, incorpore a des compositions liquides pour le nettoyage de la peau
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US5834409A (en) * 1995-03-31 1998-11-10 Colgate-Palmolive Company Scalp care products containing anti itching/anti irritant agents
DE10205193A1 (de) * 2002-02-08 2003-08-21 Beiersdorf Ag Diolhaltige Reinigungszubereitungen
EP1595530A1 (fr) * 2004-05-10 2005-11-16 L'oreal Composition cosmétique ou dermatologique à base d'un tensioactif, d'un acide monocarboxlique et d'un polyol
FR2943896A1 (fr) * 2009-04-01 2010-10-08 Oreal "roll-on" a forte teneur en acide salicylique.

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53145925A (en) * 1977-05-23 1978-12-19 Kanebo Ltd Solid composition for softening corneous tissue
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions
DD225913A1 (de) * 1984-06-22 1985-08-14 Miltitz Chem Werk Antibakteriell komedolytisch wirkende substanzkombination
FR2585575A1 (fr) * 1985-08-01 1987-02-06 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
WO1987004617A1 (fr) * 1986-02-04 1987-08-13 Sven Moberg Compositions pharmaceutiques contenant comme principaux constituants actifs du propylene glycol et/ou du polyethylene glycol et de l'uree, et leur utilisation
WO1989000853A1 (fr) * 1987-07-25 1989-02-09 Konrad Minninger Agent contenant de l'acide salicylique pour le traitement de dermatoses squameuses
EP0337289A1 (fr) * 1988-04-10 1989-10-18 Konrad Minninger Composition pharmaceutique contenant du dithranol pour le traitement des maladies exfoliatives de la peau

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53145925A (en) * 1977-05-23 1978-12-19 Kanebo Ltd Solid composition for softening corneous tissue
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions
DD225913A1 (de) * 1984-06-22 1985-08-14 Miltitz Chem Werk Antibakteriell komedolytisch wirkende substanzkombination
FR2585575A1 (fr) * 1985-08-01 1987-02-06 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
WO1987004617A1 (fr) * 1986-02-04 1987-08-13 Sven Moberg Compositions pharmaceutiques contenant comme principaux constituants actifs du propylene glycol et/ou du polyethylene glycol et de l'uree, et leur utilisation
WO1989000853A1 (fr) * 1987-07-25 1989-02-09 Konrad Minninger Agent contenant de l'acide salicylique pour le traitement de dermatoses squameuses
EP0337289A1 (fr) * 1988-04-10 1989-10-18 Konrad Minninger Composition pharmaceutique contenant du dithranol pour le traitement des maladies exfoliatives de la peau

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 90, no. 18, 30 April 1979, Columbus, Ohio, US; abstract no. 142079, "antikeratilizing cosmetic compositions" *
DATABASE WPI Week 8549, Derwent World Patents Index; AN 85-303718 *
S.T.N., File Supplier, KARLSRUHE, DE, File Chemical Abstracts, vol103, nŸ 220624 & JP-A-59088421, pub. 22-5-84 see the abstract *
S.T.N., File Supplier, KARLSRUHE, DE, File Embase, an=83021705 'psoriasis', Anderson, 1982 see the abstract *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013048A1 (fr) * 1993-11-12 1995-05-18 The Procter & Gamble Company Compositions desquamantes contenant de l'acide salicylique ainsi que des composes zwitterioniques
US5652228A (en) * 1993-11-12 1997-07-29 The Procter & Gamble Company Topical desquamation compositions
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5849728A (en) * 1993-11-12 1998-12-15 The Procter & Gamble Company Desquamation compositions
WO1996001101A1 (fr) * 1994-07-01 1996-01-18 The Procter & Gamble Company Compositions de desquamation
CN1107495C (zh) * 1994-07-01 2003-05-07 纺织研究院公司 去屑组合物
WO1996011572A1 (fr) * 1994-10-14 1996-04-25 Sven Moberg Composition antimicrobienne
US5834409A (en) * 1995-03-31 1998-11-10 Colgate-Palmolive Company Scalp care products containing anti itching/anti irritant agents
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
FR2740679A1 (fr) * 1995-11-03 1997-05-09 Letourneur Raymond Composition de shampooings et traitements a base d'eau de pluie
WO1997048375A3 (fr) * 1996-06-20 1998-02-05 Procter & Gamble Systeme de liberation de parfum, incorpore a des compositions liquides pour le nettoyage de la peau
WO1997048374A3 (fr) * 1996-06-20 1998-02-05 Procter & Gamble Systemes de diffusion de parfum dans des compositions de savon liquide
US5804538A (en) * 1996-06-20 1998-09-08 The Procter & Gamble Company Perfume delivery systems in liquid personal cleansing compositions
WO1997048375A2 (fr) * 1996-06-20 1997-12-24 The Procter & Gamble Company Systeme de liberation de parfum, incorpore a des compositions liquides pour le nettoyage de la peau
WO1997048374A2 (fr) * 1996-06-20 1997-12-24 The Procter & Gamble Company Systemes de diffusion de parfum dans des compositions de savon liquide
DE10205193A1 (de) * 2002-02-08 2003-08-21 Beiersdorf Ag Diolhaltige Reinigungszubereitungen
EP1595530A1 (fr) * 2004-05-10 2005-11-16 L'oreal Composition cosmétique ou dermatologique à base d'un tensioactif, d'un acide monocarboxlique et d'un polyol
FR2943896A1 (fr) * 2009-04-01 2010-10-08 Oreal "roll-on" a forte teneur en acide salicylique.

Also Published As

Publication number Publication date
GB9223034D0 (en) 1992-12-16
EP0666734A1 (fr) 1995-08-16

Similar Documents

Publication Publication Date Title
US10688117B2 (en) Topical wash composition for use in acne patients
US4514385A (en) Anti-acne compositions
US6162774A (en) Skin wash composition
RU2647479C2 (ru) Композиция для умывания в виде эмульсии, содержащая бпо
US20110082118A1 (en) Onychomycosis Treatment Delivery System
US6120756A (en) Topical anionic salicylate for disorders of the skin
US20080194662A1 (en) Cleanser composition
WO1994009755A1 (fr) Procede et composition de prevention et/ou de traitement des pellicules et de la dermatite seborrheique
US20060159714A1 (en) Use of an antioxidant in a dermatological and/or cosmetic composition
WO2014041542A2 (fr) Compositions topiques destinées au traitement de l'acné
US5667790A (en) Aluminum chlorhydrate as a treatment for acne and rosacea
EP3781152B1 (fr) Formulations topiques comprenant du strontium et du méthylsulfonylméthane (msm) et leur utilisation pour le traitement de la peau
Breneman et al. Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion.
KR20020011976A (ko) 칸디다 알비칸스가 증식한 피부 부분으로부터 여드름 및딱지를 제거하는 피부 청결 방법
EP0086228B1 (fr) Utilisation du peroxyde de carbamide pour le traitement de l'acne vulgaire
US6485714B1 (en) Use of salicylic acid for regulating hyperpigmented spots
JPH07267869A (ja) 皮膚病治療薬及び治療方法
JPH03178922A (ja) フケ抑制剤組成物
WO2006119540A1 (fr) Preparation destinee a traiter le psoriasis
GB2302808A (en) Propylene glycol with low potency corticosteroids for topical treatment of the scalp
GB2205743A (en) Cosmetic composition for prevention and/or treatment of dandruff
Stough et al. New beneficial agents in the treatment of acne vulgaris and seborrheic dermatitis
WO2024144577A1 (fr) Produit de nettoyage de la peau efficace contre le brunissement local
JPH03178921A (ja) フケ抑制剤組成物
RU2406479C1 (ru) Лечебно-профилактическая моющая композиция с пиритионом цинка и способ ее получения

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1993924089

Country of ref document: EP

ENP Entry into the national phase

Ref country code: US

Ref document number: 1995 428198

Date of ref document: 19950620

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1993924089

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993924089

Country of ref document: EP